Tilray Brands (TLRY) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Jan, 2026Executive summary
Q2 net revenue reached a record $211 million, up 9% year-over-year, with growth across all business segments.
Gross profit increased 29% to $61.2 million, with gross margin up over 500 basis points year-over-year to 29%.
Adjusted net loss improved to $2.2 million, with adjusted net loss per share at zero.
Net loss was $85.3 million, impacted by $75 million in non-cash costs and $8 million in one-time costs.
Project 420, a $25 million synergy plan, achieved $17 million in cost savings by Q2.
Financial highlights
Beverage segment net revenue grew 36% year-over-year to $63.1 million, now representing 30% of total net revenue.
International cannabis revenue up 25%; wellness net revenue increased 13% to $15 million.
Gross margin improved across all segments: beverage (40%), cannabis (35%), distribution (12%), wellness (31%).
Adjusted EBITDA was $9 million, slightly down from $10.1 million in the prior year quarter.
Cash and marketable securities stood at $252.1 million at quarter end.
Outlook and guidance
Fiscal 2025 net revenue guidance reaffirmed at $950 million to $1 billion.
Management expects SKU rationalization and new product innovation to offset a projected $20 million reduction in net sales over the fiscal year.
Anticipates revenue acceleration in the second half driven by new product launches, seasonality, and expanded distribution.
Latest events from Tilray Brands
- Acquisition creates a $500M global craft beverage platform and accelerates international growth.TLRY
M&A announcement2 Mar 2026 - Balanced growth across cannabis, beverages, and distribution, with innovation and efficiency focus.TLRY
TD Cowen 9th Annual Future of the Consumer Conference3 Feb 2026 - Record revenue and EBITDA growth, margin gains, and strong outlook for continued expansion.TLRY
Q4 20242 Feb 2026 - Q1 revenue hit $200M (+13% YoY), led by beverage growth and margin gains, with net loss improvement.TLRY
Q1 202519 Jan 2026 - Record Q2 revenue, improved net loss, and net cash position; 2026 guidance reaffirmed.TLRY
Q2 20269 Jan 2026 - Diversified global platform drives growth in cannabis, beverage, and wellness with strong financials.TLRY
Investor Presentation8 Jan 2026 - Record Q1 revenue and return to profitability driven by cannabis and distribution growth.TLRY
Q1 202622 Dec 2025 - Proxy covers director election, auditor ratification, pay, and board declassification proposals.TLRY
Proxy Filing2 Dec 2025 - Shareholders to vote on board declassification, share increase, and executive compensation reforms.TLRY
Proxy Filing2 Dec 2025